Sirnaomics puts off an IPO a little longer as it pockets another megaround. Is an S-1 around the corner this time?
Back in October, when small interfering RNA player Sirnaomics landed its Series D round, CEO Patrick Lu said he was open to preparing for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
